Clinical Trial

Iparomlimab and Tuvonralimab Combined With GC in Advanced ICC

Name: Iparomlimab and Tuvonralimab Combined With GC in Advanced ICC — clinical trial record (NCT07152769)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: ITUS

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This study is a randomized, controlled, open-label, single center clinical study. This study is designed to evaluate the efficacy and safety of Iparomlimab and Tuvonralimab Combined With GC versus Sintilimab Combined With GC as first-line therapy in advanced ICC.

Trial Details

NCT Number	NCT07152769
Lead Sponsor	Fudan University
Conditions	Advanced Intrahepatic Cholangiocarcinoma
Enrollment	104 participants
Start Date	2025-10-15
Primary Completion	2028-02-29 (estimated)
Study Completion	2028-12-31 (estimated)
Updated on ClinicalTrials.gov	2025-09-03